Novo Stock Is Down More Than 70% From Its Peak. Value Trap or Generational Buying Opportunity?
Key PointsNovo Nordisk rose dramatically because investors were excited after it launched the first GLP-1 weight-loss drug.
Key PointsNovo Nordisk rose dramatically because investors were excited after it launched the first GLP-1 weight-loss drug.